On November 22, 2023, Vitura Health Limited responded to the Elizabeth Sarah Jansen comments as incorrect, false and/or misleading statements. Further, Vitura Health Limited board clarified on resolution 4 that, the proposal does not ask shareholders to approve the grant of new shares, options or performance rights under the Amended Plan. This resolution was triggered by legislative changes.

In addition, Vitura Health Limited stated that, there is no certainty that all, or any, performance rights will vest and convert into shares. The increase in remuneration to Mr. Cocks, Mr. Headley?s followed an independent benchmarking review by the Company?s remuneration committee supported by reports from two separate independent remuneration experts. As well as, Vitura Health Limited also clarified on the shares were not issued to Doctors on Demand Pty Ltd. Instead, they were issued to the Regal Nominee, being Merrill Lynch (Australia) Nominees Pty Limited, as partial consideration (with a value of $6.25 million) for the acquisition of Doctors on Demand Pty Ltd. Further, Vitura Health Limited stated that under Listing Rule 7.1, all ASX-listed companies may issue up to 15% of their issued capital in a 12-month period without shareholder approval.